Clinical Trial Update: Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal teriparatide to improve bone mineral density in postmenopausal women with low bone density has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Nastech Pharmaceutical Company, Inc. | Conditions: Osteopenia, Osteoporosis | Phase 2 | Status: WITHDRAWN